320 related articles for article (PubMed ID: 12683415)
1. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections.
Tan EL; Peh SC; Sam CK
J Med Virol; 2003 Feb; 69(2):251-7. PubMed ID: 12683415
[TBL] [Abstract][Full Text] [Related]
2. The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma.
Li DJ; Bei JX; Mai SJ; Xu JF; Chen LZ; Zhang RH; Yu XJ; Hong MH; Zeng YX; Kang T
J Med Virol; 2009 Jul; 81(7):1253-60. PubMed ID: 19475622
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma.
Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P
J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009
[TBL] [Abstract][Full Text] [Related]
4. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.
Correa RM; Fellner MD; Alonio LV; Durand K; Teyssié AR; Picconi MA
J Med Virol; 2004 Aug; 73(4):583-8. PubMed ID: 15221903
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of the Taiwan variant of the Epstein-Barr virus in nasopharyngeal carcinoma patients and normal individuals.
Shu CH; Tu TY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):288-93. PubMed ID: 10820907
[TBL] [Abstract][Full Text] [Related]
6. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
[TBL] [Abstract][Full Text] [Related]
7. Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients.
Hadhri-Guiga B; Khabir AM; Mokdad-Gargouri R; Ghorbel AM; Drira M; Daoud J; Frikha M; Jlidi R; Gargouri A
Virus Res; 2006 Jan; 115(1):24-30. PubMed ID: 16154221
[TBL] [Abstract][Full Text] [Related]
8. Nasopharyngeal carcinoma in Indonesia has a low prevalence of the 30-base pair deletion of Epstein-Barr virus latent membrane protein 1.
Nurhantari Y; Emoto N; Rahayu P; Matsuo M
Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):98-105. PubMed ID: 12971521
[TBL] [Abstract][Full Text] [Related]
9. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
10. The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma.
Chang KP; Hao SP; Lin SY; Ueng SH; Pai PC; Tseng CK; Hsueh C; Hsieh MS; Yu JS; Tsang NM
Laryngoscope; 2006 Apr; 116(4):541-6. PubMed ID: 16585856
[TBL] [Abstract][Full Text] [Related]
11. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
Tiwawech D; Srivatanakul P; Karalak A; Ishida T
J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
[TBL] [Abstract][Full Text] [Related]
12. Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates.
Wang X; Liu X; Jia Y; Chao Y; Xing X; Wang Y; Luo B
J Gen Virol; 2010 Oct; 91(Pt 10):2564-73. PubMed ID: 20554797
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.
See HS; Yap YY; Yip WK; Seow HF
World J Surg Oncol; 2008 Feb; 6():18. PubMed ID: 18275617
[TBL] [Abstract][Full Text] [Related]
15. High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract.
Tai YC; Kim LH; Peh SC
Pathol Int; 2004 Mar; 54(3):158-66. PubMed ID: 14989738
[TBL] [Abstract][Full Text] [Related]
16. Loss of an XhoI-site within N-terminal region of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma.
Lin SX; Zong YS; Wu QL; Han AJ; Liang YJ
Ai Zheng; 2003 Nov; 22(11):1147-51. PubMed ID: 14613641
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.
Chen ML; Tsai CN; Liang CL; Shu CH; Huang CR; Sulitzeanu D; Liu ST; Chang YS
Oncogene; 1992 Nov; 7(11):2131-40. PubMed ID: 1331932
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus in nasopharyngeal carcinoma in Indian patients.
Rathaur RG; Chitale AR; Banerjee K
Indian J Cancer; 1999; 36(2-4):80-90. PubMed ID: 10921211
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
